Skip to main content
. 2020 Jun 24;11(1):156–180. doi: 10.1016/j.apsb.2020.06.003

Table 4.

IC50 of 19d against BRD4 and PARP1 compared with RVX-208 and Olaparib.

Molecular IC50 (μmol/L)
BRD4 PARP1 BRD4(BD1) BRD4(BD2)
Rvx-208 12.7 1.387 0.053
Olaparib 0.0013
19d 0.4 4.6 0.44 0.379

‒Not applicable.